Press Release Contact

Press release:
Medical Breakthrough: CRISPR Gene Editing Technology from MIT and Harvard Phase 3: Aridis Pharmaceuticals (Nasdaq: ARDS)
June 10, 2021, 11:59 GMT

For questions about this press release, please contact the person or organization listed below.

Dr. Vu L. Truong CEO and Founder
Aridis Pharmaceuticals, Inc.
+1 408-385-1742
Visit us on social media:
Facebook
LinkedIn